These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 15449968)

  • 1. Treatment of ocular inflammation in children.
    Thadani SM; Foster CS
    Paediatr Drugs; 2004; 6(5):289-301. PubMed ID: 15449968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
    Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
    Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic therapy with conventional and novel immunomodulatory agents for ocular inflammatory disease.
    Durrani K; Zakka FR; Ahmed M; Memon M; Siddique SS; Foster CS
    Surv Ophthalmol; 2011; 56(6):474-510. PubMed ID: 22117884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclophosphamide or Rituximab Treatment of Scleritis and Uveitis for Patients with Granulomatosis with Polyangiitis.
    Ahmed A; Foster CS
    Ophthalmic Res; 2019; 61(1):44-50. PubMed ID: 29635229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I.
    Lee K; Bajwa A; Freitas-Neto CA; Metzinger JL; Wentworth BA; Foster CS
    Expert Opin Pharmacother; 2014 Oct; 15(15):2141-54. PubMed ID: 25226529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic non-infectious uveitis and scleritis.
    Rossi DC; Ribi C; Guex-Crosier Y
    Swiss Med Wkly; 2019 Feb; 149():w20025. PubMed ID: 30852832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF inhibition for ophthalmic indications: current status and outlook.
    Rifkin LM; Birnbaum AD; Goldstein DA
    BioDrugs; 2013 Aug; 27(4):347-57. PubMed ID: 23568177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uveitis.
    Dunn JP
    Prim Care; 2015 Sep; 42(3):305-23. PubMed ID: 26319340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indication and effect of immunosuppression in patients with scleritis].
    Heiligenhaus A; Dück N; Michel D; Hudde T; Koch J; Steuhl KP
    Klin Monbl Augenheilkd; 2003 Jul; 220(7):471-80. PubMed ID: 12886507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presumed tuberculosis-related scleritis.
    Sainz de La Maza M; Hernanz I; Moll-Udina A; Mesquida M; Adan A; Martinez JA; Espinosa G; Llorenç V
    Br J Ophthalmol; 2023 Apr; 107(4):495-499. PubMed ID: 34799367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical continuous keratitis in a case of rheumatoid arthritis accompanying severe scleritis.
    Hata M; Nakamura T; Sotozono C; Kumagai K; Kinoshita S; Kurimoto Y
    Cornea; 2012 Dec; 31(12):1493-6. PubMed ID: 23023405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide for ocular inflammatory diseases.
    Pujari SS; Kempen JH; Newcomb CW; Gangaputra S; Daniel E; Suhler EB; Thorne JE; Jabs DA; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Foster CS
    Ophthalmology; 2010 Feb; 117(2):356-65. PubMed ID: 19969366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis.
    Sobrin L; Christen W; Foster CS
    Ophthalmology; 2008 Aug; 115(8):1416-21, 1421.e1. PubMed ID: 18221998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Approach for the Diagnosis and Management of Noninfective Scleritis.
    Dutta Majumder P; Agrawal R; McCluskey P; Biswas J
    Asia Pac J Ophthalmol (Phila); 2020 Dec; 10(2):212-223. PubMed ID: 33290287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and Management of Inflammatory Eye Disease in Patients with Hidradenitis Suppurativa.
    Lee DJ; Desai S; Laurent E; Kopplin LJ
    Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1318-1323. PubMed ID: 32255701
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis.
    Murphy CC; Ayliffe WH; Booth A; Makanjuola D; Andrews PA; Jayne D
    Ophthalmology; 2004 Feb; 111(2):352-6. PubMed ID: 15019389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease.
    Cuchacovich M; Solanes F; Perez C; Verdaguer JI; Verdaguer J; Castiglione E; Carpentier C; Traipe L; Villarroel F
    J Ocul Pharmacol Ther; 2016; 32(1):55-61. PubMed ID: 26562247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment strategies for scleritis and uveitis associated with inflammatory bowel disease.
    Soukiasian SH; Foster CS; Raizman MB
    Am J Ophthalmol; 1994 Nov; 118(5):601-11. PubMed ID: 7977573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management.
    Foster CS; Kothari S; Anesi SD; Vitale AT; Chu D; Metzinger JL; Cerón O
    Surv Ophthalmol; 2016; 61(1):1-17. PubMed ID: 26164736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular inflammation in Crohn's disease.
    Salmon JF; Wright JP; Murray AD
    Ophthalmology; 1991 Apr; 98(4):480-4. PubMed ID: 2052301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.